Corteva, Inc. (NYSE:CTVA – Get Free Report) CEO Luther Iv Kissam purchased 32,292 shares of the stock in a transaction dated Friday, November 13th. The shares were purchased at an average cost of $9.30 per share, for a total transaction of $300,315.60. Following the transaction, the chief executive officer owned 185,379 shares in the company, valued at approximately $1,724,024.70. The trade was a 21.09% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Corteva Trading Down 4.4%
Shares of CTVA opened at $9.02 on Tuesday. The company has a current ratio of 1.56, a quick ratio of 1.10 and a debt-to-equity ratio of 0.14. Corteva, Inc. has a 12-month low of $8.87 and a 12-month high of $90.97. The firm has a 50-day moving average price of $35.65 and a 200 day moving average price of $69.25. The firm has a market capitalization of $6.02 billion, a P/E ratio of 4.75, a P/E/G ratio of 1.72 and a beta of 0.58.
Corteva Cuts Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 2.2%. This is a drop from Corteva’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend is Tuesday, December 1st. Corteva’s payout ratio is presently 37.89%.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the stock. Weiss Ratings lowered shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. JPMorgan Chase & Co. cut their price target on shares of Corteva from $19.00 to $16.00 and set an “overweight” rating for the company in a report on Friday. Argus reaffirmed a “buy” rating and set a $91.00 price target on shares of Corteva in a research report on Friday, September 18th. Morgan Stanley reaffirmed an “overweight” rating and set a $18.00 price target on shares of Corteva in a research report on Friday, October 2nd. Finally, BMO Capital Markets set a $15.00 price objective on Corteva in a report on Friday, October 2nd. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $52.47.
Read Our Latest Research Report on CTVA
Institutional Trading of Corteva
A number of hedge funds and other institutional investors have recently modified their holdings of CTVA. Wellington Management Group LLP boosted its holdings in Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares during the period. Rakuten Investment Management Inc. purchased a new stake in Corteva during the 2nd quarter worth about $9,132,000. Kingsview Wealth Management LLC purchased a new stake in Corteva during the 2nd quarter worth about $1,093,000. ZWJ Investment Counsel Inc. increased its holdings in Corteva by 19.1% during the 3rd quarter. ZWJ Investment Counsel Inc. now owns 915,449 shares of the company’s stock worth $71,085,000 after purchasing an additional 146,644 shares during the period. Finally, Jupiter Topco LLC acquired a new stake in Corteva in the 2nd quarter valued at about $544,246,000. 81.54% of the stock is owned by institutional investors and hedge funds.
Corteva Company Profile
Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.
Featured Articles
- Five stocks we like better than Corteva
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
